Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 3
2008 3
2009 15
2010 29
2011 35
2012 30
2013 16
2014 31
2015 17
2016 31
2017 23
2018 20
2019 10
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

222 results
Results by year
Filters applied: . Clear all
Page 1
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
Zeiser R, et al. Leukemia 2015 - Clinical Trial. PMID 26228813 Free PMC article.
In this retrospective survey, 19 stem cell transplant centers in Europe and the United States reported outcome data from 95 patients who had received ruxolitinib as salvage therapy for SR-GVHD. ...
In this retrospective survey, 19 stem cell transplant centers in Europe and the United States reported outcome data from 95 pa …
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
Miklos D, et al. Blood 2017 - Clinical Trial. PMID 28924018 Free PMC article.
Based on these results, ibrutinib was approved in the United States for treatment of adult patients with cGVHD after failure of 1 or more lines of systemic therapy. ...
Based on these results, ibrutinib was approved in the United States for treatment of adult patients with cGVHD after failure o …
222 results
Jump to page
Feedback